Fragile Endothelium and Brain Dysregulated Neurochemical Activity in COVID-19

14Citations
Citations of this article
75Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Immune system and renin-angiotensin-aldosterone system dysregulation with associated cytokine release syndrome may be a key feature of early stage of SARS-CoV-2 organotropism and infection. Following viral mediated brain injury, dysregulated neurochemical activity may cause neurogenic stress cardiomyopathy, which is characterized by transient myocardial dysfunction and arrhythmias. Cardiomyopathy along with acute acute inflammatory thromboembolism and endotheliitis (fragile endothelium) might at least partially explain the underlying mechanisms of rapidly evolving life-threatening COVID-19. Further studies are clearly required to explore these complex pathologies.

Cite

CITATION STYLE

APA

Alharthy, A., Faqihi, F., Memish, Z. A., & Karakitsos, D. (2020, August 5). Fragile Endothelium and Brain Dysregulated Neurochemical Activity in COVID-19. ACS Chemical Neuroscience. American Chemical Society. https://doi.org/10.1021/acschemneuro.0c00437

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free